Pretreatment and postresection epidermal growth factor receptor (EGFR) pathway mutations in a prospective phase II trial (EXCITE) of preoperative cetuximab-containing chemoradiation (CRT) in locally advanced rectal cancer (LARC).
Simon Gollins
Honoraria - Roche
Research Funding - Merck Serono
Philip Quirke
No relevant relationships to disclose
Sun Myint
No relevant relationships to disclose
Mark P. Saunders
No relevant relationships to disclose
David Sebag-Montefiore
No relevant relationships to disclose
Shabbir Susnerwala
No relevant relationships to disclose
Sharadah Essapen
No relevant relationships to disclose
Leslie M. Samuel
No relevant relationships to disclose
Bruce Sizer
No relevant relationships to disclose
Sandy Beare
No relevant relationships to disclose
Lawrie Emma
No relevant relationships to disclose
Mark Jitlal
No relevant relationships to disclose
Nicholas West
No relevant relationships to disclose